市場調査レポート
商品コード
1384832

植込み型除細動器の世界市場規模、シェア、産業動向分析レポート:タイプ別、製品タイプ別、NYHAクラス別、エンドユース別、地域別展望と予測、2023年~2030年

Global Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Regional Outlook and Forecast, 2023 - 2030

出版日: | 発行: KBV Research | ページ情報: 英文 286 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
植込み型除細動器の世界市場規模、シェア、産業動向分析レポート:タイプ別、製品タイプ別、NYHAクラス別、エンドユース別、地域別展望と予測、2023年~2030年
出版日: 2023年10月31日
発行: KBV Research
ページ情報: 英文 286 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

植込み型除細動器市場規模は2030年までに56億米ドルに達し、予測期間中にCAGR 6.1%の市場成長率で上昇すると予測されています。

しかし、ICDは高額であるため、一部の患者、特に医療保険が十分に適用されない患者やヘルスケアサービスが限られている地域に住む患者にとっては経済的な障壁となる可能性があります。社会経済的格差やヘルスケアへのアクセス格差は、ICD治療を受けられる人々に影響を与える可能性があります。一部の恵まれない人々は、ICDを使用する上でより大きな課題に直面しています。ICD植え込み術を行う専門ヘルスケア施設や訓練を受けた心臓電気生理学者へのアクセスは、農村部や十分なサービスを受けていない地域では限られています。地理的な格差はICD治療へのアクセスに影響します。植え込み型除細動器のコストと入手のしやすさは、ヘルスケアの現場における重要な課題です。

さらに、パンデミックの初期段階では、多くの病院やヘルスケア施設がICD植え込みを含む選択的治療を延期し、COVID-19患者を優先してリソースを節約しました。このため、地域によってはICDの植え込みが減少しました。パンデミックはICDの遠隔モニタリング技術の採用を加速させました。直接訪問することが制限され、あるいは推奨されなくなったため、ヘルスケアプロバイダーは機器の機能や患者の状態を評価するために遠隔モニタリングに頼ることが多くなっています。この動向はパンデミック後も続き、患者ケアの柔軟性が増しました。このようなサービスは対面での処置に取って代わるものではないが、患者のモニタリングと管理には一定の役割を果たしました。COVID-19は市場に中程度の影響を与えました。

タイプの展望

タイプ別では、単室ICD、二室ICD、両室ICDに分類されます。2022年の市場では、デュアルチャンバーICDが大きな収益シェアを獲得しました。デュアルチャンバーICDは、心房と心室の両方をモニタリングできるため、より高度な不整脈検出アルゴリズムが可能になるという利点があります。この検出能力の向上により、不適切なショックを減らし、患者の予後を改善することができます。多くのデュアルチャンバーICDは心房と心室の両方にペーシング機能を有しています。この機能は、房室ブロックやシックサイナス症候群など、適切な心臓機能を維持するために生理的ペーシングが必要な患者にとって有益です。

製品タイプの展望

製品タイプ別では、市場は経静脈型と皮下型に分類されます。2022年には、経静脈型が市場で最も高い売上シェアを占めました。経静脈型ICDは、さまざまな心疾患のために突然の心停止のリスクを抱える患者を含む多くの患者に適しています。このような幅広い患者への適応が、このデバイスの潜在的な市場を拡大しています。経静脈的ICD技術の継続的な進歩により、電池寿命が向上し、高度な不整脈検出アルゴリズムを搭載した、より小型で高機能な機器が開発されています。これらの進歩により、経静脈ICDは患者とヘルスケアプロバイダーの双方にとってより魅力的なものとなっています。

NYHAクラスの展望

NYHAクラス別に見ると、市場はNYHAクラスIIとNYHAクラスIIIに分けられます。2022年の市場では、NYHAクラスIIIが大きな収益シェアを獲得しました。ICD植え込みの主な適応症の1つは、心室性不整脈のリスクが高い心不全患者の心臓突然死のリスクを低減することです。左室駆出率(LVEF)の低下や心室性不整脈の既往など、特定の危険因子を有するNYHA III度患者は、SCDを予防するためにICD治療が考慮されます。

最終用途の展望

エンドユース別では、市場は病院、外来手術センター、その他に細分化されます。2022年には、病院セグメントが市場で最大の収益シェアを記録しました。病院は、ICD植え込み手技のために管理された無菌環境を提供し、患者の最高レベルのケアと安全性を保証します。病院には心臓電気生理学者や、ICDの植え込み、プログラミング、フォローアップケアに関する豊富な訓練と専門知識を持つ心臓専門チームがいます。主要な病院には、ICD植え込み手技に不可欠な高度な心臓カテーテル検査室や手術室などの最新設備が整っています。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。2022年には、北米地域が最も高い収益シェアを獲得して市場をリードしました。北米では、ヘルスケア、クリニック、その他の医療施設が発達し、近代化されています。さらに、同地域では高血圧などの心血管疾患(CVD)の有病率も高く、ICDが必要とされています。メドトロニック、アボット、ボストン・サイエンティフィック・コーポレーションなどの大手メーカーが市場をさらに強化しており、メドトロニックは血管外ICD(EV-ICD)を発売し、大きなビジネスチャンスをもたらしています。さらに、中国、インド、日本の企業は革新的なヘルスケアソリューションを積極的に開発・導入しており、地域市場の発展を牽引しています。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場の概要

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
  • ポーターファイブフォース分析

第4章 植込み型除細動器市場で展開される戦略

第5章 植込み型除細動器の世界市場:タイプ別

  • 世界の両心室デバイス市場:地域別
  • 世界のデュアルチャンバーICD市場:地域別
  • 世界のシングルチャンバーICD市場:地域別

第6章 世界の市場:製品タイプ別

  • 世界の経静脈市場:地域別
  • 世界の皮下市場:地域別

第7章 世界の市場、NYHAクラス別

  • 世界のNYHAクラスII市場:地域別
  • 世界のNYHAクラスIII市場:地域別

第8章 世界の市場:最終用途別

  • 世界の病院市場:地域別
  • 世界の外来手術センター市場:地域別
  • 世界のその他の市場:地域別

第9章 世界の市場:地域別

  • 北米の市場
    • 北米の市場:タイプ別
      • 北米の国別両心室デバイス市場
      • 北米の国別デュアルチャンバーICD市場
      • 北米の国別シングルチャンバーICD市場
    • 北米の市場:製品タイプ別
      • 北米の国別経静脈市場
      • 北米の国別皮下市場
    • 北米の市場NYHAクラス別
      • 北米の国別NYHAクラスII市場
      • 北米の国別NYHAクラスIII市場
    • 北米の市場:最終用途別
      • 北米の国別病院市場
      • 北米の国別外来手術センター市場
      • 北米その他の国別市場
    • 北米の市場:国別
      • 米国の植込み型除細動器市場
      • カナダの植込み型除細動器市場
      • メキシコの植込み型除細動器市場
      • その他の北米市場
  • 欧州の市場
    • 欧州の市場:タイプ別
      • 欧州の国別両心室デバイス市場
      • 欧州の国別デュアルチャンバーICD市場
      • 欧州の国別シングルチャンバーICD市場
    • 欧州の市場:製品タイプ別
      • 欧州の国別経静脈市場
      • 欧州の国別皮下市場
    • 欧州の市場NYHAクラス別
      • 欧州の国別NYHAクラスII市場
      • 欧州の国別NYHAクラスIII市場
    • 欧州の市場:最終用途別
      • 欧州の国別病院市場
      • 欧州の外来手術センター市場:(国別)
      • 欧州のその他の国別市場
    • 欧州の市場:国別
      • ドイツの植込み型除細動器市場
      • 英国の植込み型除細動器市場
      • フランスの植込み型除細動器市場
      • ロシアの植込み型除細動器市場
      • スペインの植込み型除細動器市場
      • イタリアの植込み型除細動器市場
      • その他の欧州市場
  • アジア太平洋の市場
    • アジア太平洋の市場:タイプ別
      • アジア太平洋の両心室デバイス市場:(国別)
      • アジア太平洋の国別デュアルチャンバーICD市場
      • アジア太平洋の国別シングルチャンバーICD市場
    • アジア太平洋の市場:製品タイプ別
      • アジア太平洋の国別経静脈市場
      • アジア太平洋の国別皮下市場
    • アジア太平洋の市場NYHAクラス別
      • アジア太平洋の国別NYHAクラスII市場
      • アジア太平洋の国別NYHAクラスIII市場
    • アジア太平洋の市場:最終用途別
      • アジア太平洋の国別病院市場
      • アジア太平洋の外来手術センター市場:(国別)
      • アジア太平洋その他の国別市場
    • アジア太平洋の市場:国別
      • 中国の植込み型除細動器市場
      • 日本の植込み型除細動器市場
      • インドの植込み型除細動器市場
      • 韓国の植込み型除細動器市場
      • シンガポールの植込み型除細動器市場
      • マレーシアの植込み型除細動器市場
      • その他のアジア太平洋市場
  • ラテンアメリカ・中東・アフリカの市場
    • ラテンアメリカ・中東・アフリカの市場:タイプ別
      • ラテンアメリカ・中東・アフリカの国別両心室デバイス市場
      • ラテンアメリカ・中東・アフリカの国別デュアルチャンバーICD市場
      • ラテンアメリカ・中東・アフリカの国別シングルチャンバーICD市場
    • ラテンアメリカ・中東・アフリカの市場:製品タイプ別
      • ラテンアメリカ・中東・アフリカの国別経静脈市場
      • ラテンアメリカ・中東・アフリカの国別皮下市場
    • ラテンアメリカ・中東・アフリカの市場NYHAクラス別
      • ラテンアメリカ・中東・アフリカ国別のNYHAクラスII市場
      • ラテンアメリカ・中東・アフリカ国別のNYHAクラスIII市場
    • ラテンアメリカ・中東・アフリカの市場:最終用途別
      • ラテンアメリカ・中東・アフリカの国別病院市場
      • ラテンアメリカ・中東・アフリカの国別外来手術センター市場
      • ラテンアメリカ・中東・アフリカの国別その他市場
    • ラテンアメリカ・中東・アフリカの市場:国別
      • ブラジルの植込み型除細動器市場
      • アルゼンチンの植込み型除細動器市場
      • アラブ首長国連邦の植込み型除細動器市場
      • サウジアラビアの植込み型除細動器市場
      • 南アフリカの植込み型除細動器市場
      • ナイジェリアの植込み型除細動器市場
      • その他のラテンアメリカ・中東・アフリカの市場

第10章 企業プロファイル

  • Abbott Laboratories
  • Medtronic PLC
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • ZOLL Medical Corporation(Asahi Kasei Corporation)
  • LivaNova PLC
  • Koninklijke Philips NV
  • Getinge AB

第11章 植込み型除細動器市場の勝利の必須条件

図表

LIST OF TABLES

  • TABLE 1 Global Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 2 Global Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 3 Global Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 4 Global Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 5 Global Biventricular Devices Market, By Region, 2019 - 2022, USD Million
  • TABLE 6 Global Biventricular Devices Market, By Region, 2023 - 2030, USD Million
  • TABLE 7 Global Dual Chamber ICDs Market, By Region, 2019 - 2022, USD Million
  • TABLE 8 Global Dual Chamber ICDs Market, By Region, 2023 - 2030, USD Million
  • TABLE 9 Global Single Chamber ICDs Market, By Region, 2019 - 2022, USD Million
  • TABLE 10 Global Single Chamber ICDs Market, By Region, 2023 - 2030, USD Million
  • TABLE 11 Global Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 12 Global Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 13 Global Transvenous Market, By Region, 2019 - 2022, USD Million
  • TABLE 14 Global Transvenous Market, By Region, 2023 - 2030, USD Million
  • TABLE 15 Global Subcutaneous Market, By Region, 2019 - 2022, USD Million
  • TABLE 16 Global Subcutaneous Market, By Region, 2023 - 2030, USD Million
  • TABLE 17 Global Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 18 Global Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 19 Global NYHA Class II Market, By Region, 2019 - 2022, USD Million
  • TABLE 20 Global NYHA Class II Market, By Region, 2023 - 2030, USD Million
  • TABLE 21 Global NYHA Class III Market, By Region, 2019 - 2022, USD Million
  • TABLE 22 Global NYHA Class III Market, By Region, 2023 - 2030, USD Million
  • TABLE 23 Global Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 24 Global Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 25 Global Hospitals Market, By Region, 2019 - 2022, USD Million
  • TABLE 26 Global Hospitals Market, By Region, 2023 - 2030, USD Million
  • TABLE 27 Global Ambulatory Surgical Centers Market, By Region, 2019 - 2022, USD Million
  • TABLE 28 Global Ambulatory Surgical Centers Market, By Region, 2023 - 2030, USD Million
  • TABLE 29 Global Others Market, By Region, 2019 - 2022, USD Million
  • TABLE 30 Global Others Market, By Region, 2023 - 2030, USD Million
  • TABLE 31 Global Implantable Cardioverter Defibrillator Market, By Region, 2019 - 2022, USD Million
  • TABLE 32 Global Implantable Cardioverter Defibrillator Market, By Region, 2023 - 2030, USD Million
  • TABLE 33 North America Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 34 North America Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 35 North America Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 36 North America Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 37 North America Biventricular Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 38 North America Biventricular Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 39 North America Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 40 North America Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 41 North America Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 42 North America Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 43 North America Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 44 North America Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 45 North America Transvenous Market, By Country, 2019 - 2022, USD Million
  • TABLE 46 North America Transvenous Market, By Country, 2023 - 2030, USD Million
  • TABLE 47 North America Subcutaneous Market, By Country, 2019 - 2022, USD Million
  • TABLE 48 North America Subcutaneous Market, By Country, 2023 - 2030, USD Million
  • TABLE 49 North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 50 North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 51 North America NYHA Class II Market, By Country, 2019 - 2022, USD Million
  • TABLE 52 North America NYHA Class II Market, By Country, 2023 - 2030, USD Million
  • TABLE 53 North America NYHA Class III Market, By Country, 2019 - 2022, USD Million
  • TABLE 54 North America NYHA Class III Market, By Country, 2023 - 2030, USD Million
  • TABLE 55 North America Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 56 North America Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 57 North America Hospitals Market, By Country, 2019 - 2022, USD Million
  • TABLE 58 North America Hospitals Market, By Country, 2023 - 2030, USD Million
  • TABLE 59 North America Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
  • TABLE 60 North America Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
  • TABLE 61 North America Others Market, By Country, 2019 - 2022, USD Million
  • TABLE 62 North America Others Market, By Country, 2023 - 2030, USD Million
  • TABLE 63 North America Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
  • TABLE 64 North America Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
  • TABLE 65 US Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 66 US Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 67 US Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 68 US Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 69 US Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 70 US Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 71 US Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 72 US Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 73 US Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 74 US Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 75 Canada Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 76 Canada Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 77 Canada Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 78 Canada Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 79 Canada Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 80 Canada Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 81 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 82 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 83 Canada Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 84 Canada Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 85 Mexico Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 86 Mexico Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 87 Mexico Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 88 Mexico Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 89 Mexico Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 90 Mexico Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 91 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 92 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 93 Mexico Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 94 Mexico Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 97 Rest of North America Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 101 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 102 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 103 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 104 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 105 Europe Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 106 Europe Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 107 Europe Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 108 Europe Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 109 Europe Biventricular Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Biventricular Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 115 Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 116 Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 117 Europe Transvenous Market, By Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Transvenous Market, By Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Subcutaneous Market, By Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Subcutaneous Market, By Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 122 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 123 Europe NYHA Class II Market, By Country, 2019 - 2022, USD Million
  • TABLE 124 Europe NYHA Class II Market, By Country, 2023 - 2030, USD Million
  • TABLE 125 Europe NYHA Class III Market, By Country, 2019 - 2022, USD Million
  • TABLE 126 Europe NYHA Class III Market, By Country, 2023 - 2030, USD Million
  • TABLE 127 Europe Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 128 Europe Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 129 Europe Hospitals Market, By Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Hospitals Market, By Country, 2023 - 2030, USD Million
  • TABLE 131 Europe Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
  • TABLE 132 Europe Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
  • TABLE 133 Europe Others Market, By Country, 2019 - 2022, USD Million
  • TABLE 134 Europe Others Market, By Country, 2023 - 2030, USD Million
  • TABLE 135 Europe Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
  • TABLE 136 Europe Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
  • TABLE 137 Germany Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 138 Germany Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 139 Germany Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 140 Germany Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 141 Germany Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 142 Germany Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 143 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 144 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 145 Germany Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 146 Germany Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 147 UK Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 148 UK Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 149 UK Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 150 UK Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 151 UK Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 152 UK Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 153 UK Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 154 UK Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 155 UK Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 156 UK Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 157 France Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 158 France Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 159 France Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 160 France Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 161 France Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 162 France Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 163 France Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 164 France Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 165 France Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 166 France Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 167 Russia Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 168 Russia Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 169 Russia Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 170 Russia Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 171 Russia Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 172 Russia Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 173 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 174 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 175 Russia Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 176 Russia Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 177 Spain Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 178 Spain Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 179 Spain Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 180 Spain Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 181 Spain Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 182 Spain Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 183 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 184 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 185 Spain Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 186 Spain Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 187 Italy Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 188 Italy Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 189 Italy Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 190 Italy Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 191 Italy Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 192 Italy Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 193 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 194 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 195 Italy Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 196 Italy Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 197 Rest of Europe Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 198 Rest of Europe Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 199 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 200 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 201 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 202 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 203 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 204 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 205 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 206 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Biventricular Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Biventricular Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Dual Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Dual Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific Single Chamber ICDs Market, By Country, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific Single Chamber ICDs Market, By Country, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Transvenous Market, By Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Transvenous Market, By Country, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Subcutaneous Market, By Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Subcutaneous Market, By Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 225 Asia Pacific NYHA Class II Market, By Country, 2019 - 2022, USD Million
  • TABLE 226 Asia Pacific NYHA Class II Market, By Country, 2023 - 2030, USD Million
  • TABLE 227 Asia Pacific NYHA Class III Market, By Country, 2019 - 2022, USD Million
  • TABLE 228 Asia Pacific NYHA Class III Market, By Country, 2023 - 2030, USD Million
  • TABLE 229 Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 230 Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 231 Asia Pacific Hospitals Market, By Country, 2019 - 2022, USD Million
  • TABLE 232 Asia Pacific Hospitals Market, By Country, 2023 - 2030, USD Million
  • TABLE 233 Asia Pacific Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Million
  • TABLE 234 Asia Pacific Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Million
  • TABLE 235 Asia Pacific Others Market, By Country, 2019 - 2022, USD Million
  • TABLE 236 Asia Pacific Others Market, By Country, 2023 - 2030, USD Million
  • TABLE 237 Asia Pacific Implantable Cardioverter Defibrillator Market, By Country, 2019 - 2022, USD Million
  • TABLE 238 Asia Pacific Implantable Cardioverter Defibrillator Market, By Country, 2023 - 2030, USD Million
  • TABLE 239 China Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 240 China Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 241 China Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 242 China Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 243 China Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 244 China Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 245 China Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 246 China Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 247 China Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 248 China Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 249 Japan Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 250 Japan Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 251 Japan Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 252 Japan Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 253 Japan Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 254 Japan Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 255 Japan Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 256 Japan Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 257 Japan Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 258 Japan Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 259 India Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 260 India Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 261 India Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 262 India Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 263 India Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 264 India Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 265 India Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 266 India Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 267 India Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 268 India Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 269 South Korea Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 270 South Korea Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 271 South Korea Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 272 South Korea Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 273 South Korea Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 274 South Korea Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 275 South Korea Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 276 South Korea Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 277 South Korea Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 278 South Korea Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 279 Singapore Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 280 Singapore Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 281 Singapore Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 282 Singapore Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 283 Singapore Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 284 Singapore Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 285 Singapore Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 286 Singapore Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 287 Singapore Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 288 Singapore Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 289 Malaysia Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 290 Malaysia Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 291 Malaysia Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 292 Malaysia Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 293 Malaysia Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 294 Malaysia Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 295 Malaysia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 296 Malaysia Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 297 Malaysia Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 298 Malaysia Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
  • TABLE 299 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, 2019 - 2022, USD Million
  • TABLE 300 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, 2023 - 2030, USD Million
  • TABLE 301 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2019 - 2022, USD Million
  • TABLE 302 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Type, 2023 - 2030, USD Million
  • TABLE 303 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2019 - 2022, USD Million
  • TABLE 304 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type, 2023 - 2030, USD Million
  • TABLE 305 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2019 - 2022, USD Million
  • TABLE 306 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class, 2023 - 2030, USD Million
  • TABLE 307 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2019 - 2022, USD Million
  • TABLE 308 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use, 2023 - 2030, USD Million
目次

The Global Implantable Cardioverter Defibrillator Market size is expected to reach $5.6 billion by 2030, rising at a market growth of 6.1% CAGR during the forecast period.

The rising incidence of cardiovascular diseases, like heart failure and arrhythmias, contributes to the growing demand for ICDs. Therefore, Dual Chamber ICDs segment would generate $1,164.3 million revenue in the market in 2022. As the global population ages and lifestyle-related risk factors continue to rise, the prevalence of these conditions is expected to increase. CVD, including coronary artery disease and heart failure, is often associated with an increased risk of arrhythmias, including ventricular tachycardia (VT) and ventricular fibrillation (VF). Some of the factors impacting the market are expansion of indications for ICDs, development of MRI-compatible ICDs and high cost and limited accessibility.

Patients with ARVC at risk of ventricular arrhythmias candidates for ICD implantation. ARVC is a rare genetic disorder that affects the heart muscle and can lead to arrhythmias. Patients with inherited LQTS, associated with a higher risk of life-threatening arrhythmias, are considered for ICD therapy if they have experienced syncopal episodes or have a history of cardiac arrest. Brugada syndrome is another inherited arrhythmia disorder that can lead to sudden cardiac arrest. Additionally, the availability of MRI-compatible ICDs has significantly improved patient care by enabling individuals with ICDs to undergo essential MRI scans without needing device removal or the associated risks of potential device interactions during the scan. Additionally, the introduction of MRI-compatible ICDs expanded the ICD potential patient population. Patients often prefer Expanding indications for implantable cardioverter defibrillators (ICDs) have significantly developed the implantable cardioverter defibrillator market and the development of MRI-compatible ICDs represents a significant step forward in patient care, allowing individuals with ICDs to access essential MRI scans without compromising cardiac therapy. Thus, due to the following factors the market will expand.

However, the high cost of ICDs can create financial barriers for some patients, particularly those without adequate health insurance coverage or those living in regions with limited healthcare services. Socioeconomic disparities and disparities in healthcare access can affect who has access to ICD therapy. Some underserved populations face greater challenges in accessing ICDs. Access to specialized healthcare facilities and trained cardiac electrophysiologists who perform ICD implantation procedures are limited in rural or underserved areas. Geographic disparities can affect access to ICD therapy. The cost and accessibility of implantable cardioverter defibrillators are significant challenges in the healthcare landscape.

Furthermore, during the early stages of the pandemic, many hospitals and healthcare facilities postponed elective procedures, including ICD implantations, to prioritize COVID-19 patients and conserve resources. This led to a decline in ICD implantations in some regions. The pandemic accelerated the adoption of remote monitoring technology for ICDs. With in-person visits restricted or discouraged, healthcare providers increasingly relied on remote monitoring to assess device function and patient status. This trend continued even after the pandemic as it offered more flexibility in patient care. While these services are not a replacement for in-person procedures, they played a role in patient monitoring and management. COVID-19 had a moderate effect on the market.

Type Outlook

Based on type, the market is classified into single chamber ICDs, dual chamber ICDs, and biventricular devices. The dual chamber ICDs segment acquired a substantial revenue share in the market in 2022. Dual-chamber ICDs have the advantage of monitoring both the atrium and ventricle, which allows for more sophisticated arrhythmia detection algorithms. This improved detection capability can help reduce inappropriate shocks and improve patient outcomes. Many dual-chamber ICDs have pacing capabilities for both the atrium and ventricle. This feature can benefit patients who require physiological pacing to maintain proper heart function, such as those with atrioventricular (AV) block or sick sinus syndrome.

Product Type Outlook

By product type, the market is categorized into transvenous and subcutaneous. In 2022, the transvenous segment held the highest revenue share in the market. Transvenous ICDs suit many patients, including those at risk of sudden cardiac arrest because of various cardiac conditions. This broad patient eligibility expands the potential market for these devices. Ongoing advancements in transvenous ICD technology have led to smaller, more sophisticated devices with improved battery life and advanced arrhythmia detection algorithms. These advancements make transvenous ICDs more appealing to both patients and healthcare providers.

NYHA Class Outlook

On the basis of NYHA class, the market is divided into NYHA class II and NYHA class III. The NYHA class III segment garnered a significant revenue share in the market in 2022. One of the primary indications for ICD implantation is to reduce the risk of sudden cardiac death in heart failure patients at high risk of ventricular arrhythmias. NYHA Class III patients with specific risk factors, such as a reduced left ventricular ejection fraction (LVEF) or a history of ventricular arrhythmias, are considered for ICD therapy to prevent SCD.

End-use Outlook

By end-use, the market is fragmented into hospitals, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the maximum revenue share in the market. Hospitals provide a controlled and sterile environment for ICD implantation procedures, ensuring the highest level of care and safety for patients. Hospitals have cardiac electrophysiologists and specialized cardiac teams with extensive training and expertise in ICD implantation, programming, and follow-up care. Leading hospitals have state-of-the-art facilities, including advanced cardiac catheterization labs and operating rooms, essential for ICD implantation procedures.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. Hospitals, clinics, and other healthcare facilities are well-developed and modernized in North America. Additionally, the region also experiences a high prevalence of cardiovascular diseases (CVD), such as hypertension, necessitating ICDs. The market is further strengthened by significant manufacturers like Medtronic, Abbott, and Boston Scientific Corporation, with Medtronic's launch of extravascular ICDs (EV-ICDs) presenting substantial opportunities. In addition, companies in China, India, and Japan are actively developing and introducing innovative healthcare solutions, driving the development of the regional market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Stryker Corporation, ZOLL Medical Corporation (Asahi Kasei Corporation), LivaNova PLC, Koninklijke Philips N.V. and Getinge AB.

Strategies Deployed in Implantable Cardioverter Defibrillator Market

Jul-2023: Abbott Laboratories got approval from the FDA for the AVEIR dual chamber (DR) leadless pacemaker system, an advanced medical device that offers dual-chamber pacing capabilities without the need for traditional leads or wires, improving patient comfort and reducing potential complications.

Nov-2021: Koninklijke Philips N.V. acquired Cardiology, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Through his acquisition, Koninklijke Philips N.V. would be able to strengthen its diagnostics offering and cardiac monitoring with electrocardiogram (ECG) analysis, creative software technology, and reporting services.

Apr-2021: ZOLL Medical Corporation took over Respicardia, Inc., a medical device company focused on developing innovative therapies for people with central sleep apnea. Through this acquisition, both companies jointly worked together to enhance patient outcomes through the development of groundbreaking therapies for conditions with significant unmet clinical needs.

Feb-2021: Koninklijke Philips N.V. took over BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. Through this acquisition, Koninklijke Philips N.V. would be in a favourable position to enhance patient care across care environments for medical conditions and numerous diseases with the help of the combination of both the organization's portfolio and service platforms.

Oct-2020: Abbott Laboratories introduced ICD (Implantable Cardioverter-Defibrillator), a medical device that monitors heart rhythms and delivers shocks to treat life-threatening arrhythmias, and CRT-D (Cardiac Resynchronization Therapy with Defibrillation), an ICD with an added feature to synchronize the contractions of the heart's ventricles, improving heart function in certain patients.

Apr-2019: Stryker Corporation launched LIFEPAK® CR2 Defibrillator in the United States, an advanced automated external defibrillator (AED) designed for easy use in emergency cardiac situations. The LIFEPAK CR2 is designed to improve CPR quality and deliver the quickest initial shock during defibrillation, with every aspect tailored to boost user confidence, utilizing connectivity to support comprehensive care in the chain of survival and streamline AED program management for our clients.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Biventricular Devices
  • Dual Chamber ICDs
  • Single Chamber ICDs

By Product Type

  • Transvenous
  • Subcutaneous

By NYHA Class

  • NYHA Class II
  • NYHA Class III

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Medtronic PLC
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • ZOLL Medical Corporation (Asahi Kasei Corporation)
  • LivaNova PLC
  • Koninklijke Philips N.V.
  • Getinge AB

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Implantable Cardioverter Defibrillator Market, by Type
    • 1.4.2 Global Implantable Cardioverter Defibrillator Market, by Product Type
    • 1.4.3 Global Implantable Cardioverter Defibrillator Market, by NYHA Class
    • 1.4.4 Global Implantable Cardioverter Defibrillator Market, by End-use
    • 1.4.5 Global Implantable Cardioverter Defibrillator Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Implantable Cardioverter Defibrillator Market

Chapter 5. Global Implantable Cardioverter Defibrillator Market, By Type

  • 5.1 Global Biventricular Devices Market, By Region
  • 5.2 Global Dual Chamber ICDs Market, By Region
  • 5.3 Global Single Chamber ICDs Market, By Region

Chapter 6. Global Implantable Cardioverter Defibrillator Market, By Product Type

  • 6.1 Global Transvenous Market, By Region
  • 6.2 Global Subcutaneous Market, By Region

Chapter 7. Global Implantable Cardioverter Defibrillator Market, By NYHA Class

  • 7.1 Global NYHA Class II Market, By Region
  • 7.2 Global NYHA Class III Market, By Region

Chapter 8. Global Implantable Cardioverter Defibrillator Market, By End-use

  • 8.1 Global Hospitals Market, By Region
  • 8.2 Global Ambulatory Surgical Centers Market, By Region
  • 8.3 Global Others Market, By Region

Chapter 9. Global Implantable Cardioverter Defibrillator Market, By Region

  • 9.1 North America Implantable Cardioverter Defibrillator Market
    • 9.1.1 North America Implantable Cardioverter Defibrillator Market, By Type
      • 9.1.1.1 North America Biventricular Devices Market, By Country
      • 9.1.1.2 North America Dual Chamber ICDs Market, By Country
      • 9.1.1.3 North America Single Chamber ICDs Market, By Country
    • 9.1.2 North America Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.1.2.1 North America Transvenous Market, By Country
      • 9.1.2.2 North America Subcutaneous Market, By Country
    • 9.1.3 North America Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.1.3.1 North America NYHA Class II Market, By Country
      • 9.1.3.2 North America NYHA Class III Market, By Country
    • 9.1.4 North America Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.4.1 North America Hospitals Market, By Country
      • 9.1.4.2 North America Ambulatory Surgical Centers Market, By Country
      • 9.1.4.3 North America Others Market, By Country
    • 9.1.5 North America Implantable Cardioverter Defibrillator Market, By Country
      • 9.1.5.1 US Implantable Cardioverter Defibrillator Market
        • 9.1.5.1.1 US Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.1.2 US Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.1.3 US Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.1.4 US Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.5.2 Canada Implantable Cardioverter Defibrillator Market
        • 9.1.5.2.1 Canada Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.2.2 Canada Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.2.3 Canada Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.2.4 Canada Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.5.3 Mexico Implantable Cardioverter Defibrillator Market
        • 9.1.5.3.1 Mexico Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.3.2 Mexico Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.3.3 Mexico Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.3.4 Mexico Implantable Cardioverter Defibrillator Market, By End-use
      • 9.1.5.4 Rest of North America Implantable Cardioverter Defibrillator Market
        • 9.1.5.4.1 Rest of North America Implantable Cardioverter Defibrillator Market, By Type
        • 9.1.5.4.2 Rest of North America Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.1.5.4.3 Rest of North America Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.1.5.4.4 Rest of North America Implantable Cardioverter Defibrillator Market, By End-use
  • 9.2 Europe Implantable Cardioverter Defibrillator Market
    • 9.2.1 Europe Implantable Cardioverter Defibrillator Market, By Type
      • 9.2.1.1 Europe Biventricular Devices Market, By Country
      • 9.2.1.2 Europe Dual Chamber ICDs Market, By Country
      • 9.2.1.3 Europe Single Chamber ICDs Market, By Country
    • 9.2.2 Europe Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.2.2.1 Europe Transvenous Market, By Country
      • 9.2.2.2 Europe Subcutaneous Market, By Country
    • 9.2.3 Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.2.3.1 Europe NYHA Class II Market, By Country
      • 9.2.3.2 Europe NYHA Class III Market, By Country
    • 9.2.4 Europe Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.4.1 Europe Hospitals Market, By Country
      • 9.2.4.2 Europe Ambulatory Surgical Centers Market, By Country
      • 9.2.4.3 Europe Others Market, By Country
    • 9.2.5 Europe Implantable Cardioverter Defibrillator Market, By Country
      • 9.2.5.1 Germany Implantable Cardioverter Defibrillator Market
        • 9.2.5.1.1 Germany Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.1.2 Germany Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.1.3 Germany Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.1.4 Germany Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.2 UK Implantable Cardioverter Defibrillator Market
        • 9.2.5.2.1 UK Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.2.2 UK Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.2.3 UK Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.2.4 UK Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.3 France Implantable Cardioverter Defibrillator Market
        • 9.2.5.3.1 France Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.3.2 France Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.3.3 France Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.3.4 France Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.4 Russia Implantable Cardioverter Defibrillator Market
        • 9.2.5.4.1 Russia Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.4.2 Russia Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.4.3 Russia Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.4.4 Russia Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.5 Spain Implantable Cardioverter Defibrillator Market
        • 9.2.5.5.1 Spain Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.5.2 Spain Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.5.3 Spain Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.5.4 Spain Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.6 Italy Implantable Cardioverter Defibrillator Market
        • 9.2.5.6.1 Italy Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.6.2 Italy Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.6.3 Italy Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.6.4 Italy Implantable Cardioverter Defibrillator Market, By End-use
      • 9.2.5.7 Rest of Europe Implantable Cardioverter Defibrillator Market
        • 9.2.5.7.1 Rest of Europe Implantable Cardioverter Defibrillator Market, By Type
        • 9.2.5.7.2 Rest of Europe Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.2.5.7.3 Rest of Europe Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.2.5.7.4 Rest of Europe Implantable Cardioverter Defibrillator Market, By End-use
  • 9.3 Asia Pacific Implantable Cardioverter Defibrillator Market
    • 9.3.1 Asia Pacific Implantable Cardioverter Defibrillator Market, By Type
      • 9.3.1.1 Asia Pacific Biventricular Devices Market, By Country
      • 9.3.1.2 Asia Pacific Dual Chamber ICDs Market, By Country
      • 9.3.1.3 Asia Pacific Single Chamber ICDs Market, By Country
    • 9.3.2 Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.3.2.1 Asia Pacific Transvenous Market, By Country
      • 9.3.2.2 Asia Pacific Subcutaneous Market, By Country
    • 9.3.3 Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.3.3.1 Asia Pacific NYHA Class II Market, By Country
      • 9.3.3.2 Asia Pacific NYHA Class III Market, By Country
    • 9.3.4 Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.4.1 Asia Pacific Hospitals Market, By Country
      • 9.3.4.2 Asia Pacific Ambulatory Surgical Centers Market, By Country
      • 9.3.4.3 Asia Pacific Others Market, By Country
    • 9.3.5 Asia Pacific Implantable Cardioverter Defibrillator Market, By Country
      • 9.3.5.1 China Implantable Cardioverter Defibrillator Market
        • 9.3.5.1.1 China Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.1.2 China Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.1.3 China Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.1.4 China Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.2 Japan Implantable Cardioverter Defibrillator Market
        • 9.3.5.2.1 Japan Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.2.2 Japan Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.2.3 Japan Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.2.4 Japan Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.3 India Implantable Cardioverter Defibrillator Market
        • 9.3.5.3.1 India Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.3.2 India Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.3.3 India Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.3.4 India Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.4 South Korea Implantable Cardioverter Defibrillator Market
        • 9.3.5.4.1 South Korea Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.4.2 South Korea Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.4.3 South Korea Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.4.4 South Korea Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.5 Singapore Implantable Cardioverter Defibrillator Market
        • 9.3.5.5.1 Singapore Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.5.2 Singapore Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.5.3 Singapore Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.5.4 Singapore Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.6 Malaysia Implantable Cardioverter Defibrillator Market
        • 9.3.5.6.1 Malaysia Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.6.2 Malaysia Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.6.3 Malaysia Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.6.4 Malaysia Implantable Cardioverter Defibrillator Market, By End-use
      • 9.3.5.7 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market
        • 9.3.5.7.1 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Type
        • 9.3.5.7.2 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.3.5.7.3 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.3.5.7.4 Rest of Asia Pacific Implantable Cardioverter Defibrillator Market, By End-use
  • 9.4 LAMEA Implantable Cardioverter Defibrillator Market
    • 9.4.1 LAMEA Implantable Cardioverter Defibrillator Market, By Type
      • 9.4.1.1 LAMEA Biventricular Devices Market, By Country
      • 9.4.1.2 LAMEA Dual Chamber ICDs Market, By Country
      • 9.4.1.3 LAMEA Single Chamber ICDs Market, By Country
    • 9.4.2 LAMEA Implantable Cardioverter Defibrillator Market, By Product Type
      • 9.4.2.1 LAMEA Transvenous Market, By Country
      • 9.4.2.2 LAMEA Subcutaneous Market, By Country
    • 9.4.3 LAMEA Implantable Cardioverter Defibrillator Market, By NYHA Class
      • 9.4.3.1 LAMEA NYHA Class II Market, By Country
      • 9.4.3.2 LAMEA NYHA Class III Market, By Country
    • 9.4.4 LAMEA Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.4.1 LAMEA Hospitals Market, By Country
      • 9.4.4.2 LAMEA Ambulatory Surgical Centers Market, By Country
      • 9.4.4.3 LAMEA Others Market, By Country
    • 9.4.5 LAMEA Implantable Cardioverter Defibrillator Market, By Country
      • 9.4.5.1 Brazil Implantable Cardioverter Defibrillator Market
        • 9.4.5.1.1 Brazil Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.1.2 Brazil Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.1.3 Brazil Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.1.4 Brazil Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.2 Argentina Implantable Cardioverter Defibrillator Market
        • 9.4.5.2.1 Argentina Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.2.2 Argentina Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.2.3 Argentina Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.2.4 Argentina Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.3 UAE Implantable Cardioverter Defibrillator Market
        • 9.4.5.3.1 UAE Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.3.2 UAE Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.3.3 UAE Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.3.4 UAE Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.4 Saudi Arabia Implantable Cardioverter Defibrillator Market
        • 9.4.5.4.1 Saudi Arabia Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.4.2 Saudi Arabia Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.4.3 Saudi Arabia Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.4.4 Saudi Arabia Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.5 South Africa Implantable Cardioverter Defibrillator Market
        • 9.4.5.5.1 South Africa Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.5.2 South Africa Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.5.3 South Africa Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.5.4 South Africa Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.6 Nigeria Implantable Cardioverter Defibrillator Market
        • 9.4.5.6.1 Nigeria Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.6.2 Nigeria Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.6.3 Nigeria Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.6.4 Nigeria Implantable Cardioverter Defibrillator Market, By End-use
      • 9.4.5.7 Rest of LAMEA Implantable Cardioverter Defibrillator Market
        • 9.4.5.7.1 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By Type
        • 9.4.5.7.2 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By Product Type
        • 9.4.5.7.3 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By NYHA Class
        • 9.4.5.7.4 Rest of LAMEA Implantable Cardioverter Defibrillator Market, By End-use

Chapter 10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Segmental and Regional Analysis
    • 10.1.4 Research & Development Expense
    • 10.1.5 Recent strategies and developments:
      • 10.1.5.1 Product Launches and Product Expansions:
      • 10.1.5.2 Trails and Approvals:
    • 10.1.6 SWOT Analysis
  • 10.2 Medtronic PLC
    • 10.2.1 Company overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Segmental and Regional Analysis
    • 10.2.4 Research & Development Expenses
    • 10.2.5 SWOT Analysis
  • 10.3 Biotronik SE & Co. KG
    • 10.3.1 Company Overview
    • 10.3.2 SWOT Analysis
  • 10.4 Boston Scientific Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental and Regional Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 SWOT Analysis
  • 10.5 MicroPort Scientific Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Segmental and Regional Analysis
    • 10.5.4 Research & Development Expense
    • 10.5.5 SWOT Analysis
  • 10.6 Stryker Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expense
    • 10.6.5 Recent strategies and developments:
      • 10.6.5.1 Product Launches and Product Expansions:
    • 10.6.6 SWOT Analysis
  • 10.7 ZOLL Medical Corporation (Asahi Kasei Corporation)
    • 10.7.1 Company Overview
    • 10.7.2 Financial Analysis
    • 10.7.3 Segmental and Regional Analysis
    • 10.7.4 Research & Development Expense
    • 10.7.5 Recent strategies and developments:
      • 10.7.5.1 Acquisition and Mergers:
    • 10.7.6 SWOT Analysis
  • 10.8 LivaNova PLC
    • 10.8.1 Company Overview
    • 10.8.2 Financial Analysis
    • 10.8.3 Segmental and Regional Analysis
    • 10.8.4 Research & Development Expense
    • 10.8.5 SWOT Analysis
  • 10.9 Koninklijke Philips N.V.
    • 10.9.1 Company Overview
    • 10.9.2 Financial Analysis
    • 10.9.3 Segmental and Regional Analysis
    • 10.9.4 Research & Development Expense
    • 10.9.5 Recent strategies and developments:
      • 10.9.5.1 Acquisition and Mergers:
    • 10.9.6 SWOT Analysis
  • 10.10. Getinge AB
    • 10.10.1 Company Overview
    • 10.10.2 Financial Analysis
    • 10.10.3 Segmental and Regional Analysis
    • 10.10.4 Research & Development Expense
    • 10.10.5 SWOT Analysis

Chapter 11. Winning imperatives of Implantable Cardioverter Defibrillator Market